Detalhe da pesquisa
1.
STAT6 suppression prevents bleomycin-induced dermal fibrosis.
FASEB J
; 37(2): e22761, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629780
2.
Methods for objective assessment of skin involvement in systemic sclerosis.
Curr Opin Rheumatol
; 35(6): 301-308, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605869
3.
Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression.
Rheumatology (Oxford)
; 62(4): 1662-1668, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040182
4.
Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.
Rheumatology (Oxford)
; 62(9): 3197-3204, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708011
5.
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization.
Rheumatology (Oxford)
; 62(10): 3433-3438, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37079727
6.
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
Rheumatology (Oxford)
; 62(5): 1877-1886, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173318
7.
Interstitial lung disease in patients with systemic sclerosis: what can we learn from the SENSCIS trial?
Clin Exp Rheumatol
; 41(8): 1713-1719, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534955
8.
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation.
Clin Exp Rheumatol
; 41(8): 1632-1638, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497718
9.
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit.
Curr Opin Rheumatol
; 34(6): 357-364, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125916
10.
Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease.
Ann Rheum Dis
; 81(6): 854-860, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190386
11.
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time.
Ann Rheum Dis
; 81(4): 516-523, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937693
12.
High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey.
Clin Exp Rheumatol
; 40(10): 1951-1955, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819810
13.
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
Ann Rheum Dis
; 80(8): 1040-1047, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096881
14.
Genomic Risk Score impact on susceptibility to systemic sclerosis.
Ann Rheum Dis
; 80(1): 118-127, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004331
15.
Predictors of progression in systemic sclerosis patients with interstitial lung disease.
Eur Respir J
; 55(5)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079645
16.
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial.
Ann Rheum Dis
; 79(11): 1478-1484, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759258
17.
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile.
Ann Rheum Dis
; 79(3): 379-386, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767698
18.
Type I interferon dysregulation in Systemic Sclerosis.
Cytokine
; 132: 154635, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30685202
19.
Biomarkers in systemic sclerosis.
Curr Opin Rheumatol
; 31(6): 595-602, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31436584
20.
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Ann Rheum Dis
; 78(11): 1583-1591, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439591